James Rudd
@18fdg.bsky.social
Cardiologist and Professor in Cambridge. Podcast host at BMJ Heart. Tech-lover. Imaging, data and AI to improve health. Deputy CCIO @CUH_NHS. #GTFC supporter.
Reposted by James Rudd
Fresh off her @naturemedicine.bsky.social paper.
@rouchelles.bsky.social talks balancing work and life, navigating academic cardiology as a woman, and why even top achievers face imposter syndrome.
Read more ⬇️
rdcu.be/eX8W3
@nihr.bsky.social
@royalpapworth.bsky.social
@rouchelles.bsky.social talks balancing work and life, navigating academic cardiology as a woman, and why even top achievers face imposter syndrome.
Read more ⬇️
rdcu.be/eX8W3
@nihr.bsky.social
@royalpapworth.bsky.social
January 20, 2026 at 9:41 AM
Fresh off her @naturemedicine.bsky.social paper.
@rouchelles.bsky.social talks balancing work and life, navigating academic cardiology as a woman, and why even top achievers face imposter syndrome.
Read more ⬇️
rdcu.be/eX8W3
@nihr.bsky.social
@royalpapworth.bsky.social
@rouchelles.bsky.social talks balancing work and life, navigating academic cardiology as a woman, and why even top achievers face imposter syndrome.
Read more ⬇️
rdcu.be/eX8W3
@nihr.bsky.social
@royalpapworth.bsky.social
Reposted by James Rudd
Thank you Elisa Martini for featuring the IVORY trial published in @natmed.nature.com in Nature Portfolio’s Nature CVR 🫀
Main paper: rdcu.be/eX8W3
Commentary: rdcu.be/eYyG6
@jch403.bsky.social @ziadmallat.bsky.social @18fdg.bsky.social @ivorytrial.bsky.social @mallatlab.bsky.social
Main paper: rdcu.be/eX8W3
Commentary: rdcu.be/eYyG6
@jch403.bsky.social @ziadmallat.bsky.social @18fdg.bsky.social @ivorytrial.bsky.social @mallatlab.bsky.social
January 19, 2026 at 2:26 AM
Thank you Elisa Martini for featuring the IVORY trial published in @natmed.nature.com in Nature Portfolio’s Nature CVR 🫀
Main paper: rdcu.be/eX8W3
Commentary: rdcu.be/eYyG6
@jch403.bsky.social @ziadmallat.bsky.social @18fdg.bsky.social @ivorytrial.bsky.social @mallatlab.bsky.social
Main paper: rdcu.be/eX8W3
Commentary: rdcu.be/eYyG6
@jch403.bsky.social @ziadmallat.bsky.social @18fdg.bsky.social @ivorytrial.bsky.social @mallatlab.bsky.social
Reposted by James Rudd
A new AI tool can spot abnormalities in blood cells more accurately and reliably than human doctors. It could be a game-changer for how conditions like leukaemia are diagnosed. 🩸
Called CytoDiffusion, it's unlike many other AI models. Find out how: bit.ly/4o9uJJ4 🧪
@ucl.ac.uk @qmul.bsky.social
Called CytoDiffusion, it's unlike many other AI models. Find out how: bit.ly/4o9uJJ4 🧪
@ucl.ac.uk @qmul.bsky.social
AI tool spots blood cell abnormalities missed by doctors
An AI tool that can analyse abnormalities in the shape and form of blood cells, and with greater accuracy and reliability than human experts, could change the
bit.ly
November 21, 2025 at 10:37 AM
A new AI tool can spot abnormalities in blood cells more accurately and reliably than human doctors. It could be a game-changer for how conditions like leukaemia are diagnosed. 🩸
Called CytoDiffusion, it's unlike many other AI models. Find out how: bit.ly/4o9uJJ4 🧪
@ucl.ac.uk @qmul.bsky.social
Called CytoDiffusion, it's unlike many other AI models. Find out how: bit.ly/4o9uJJ4 🧪
@ucl.ac.uk @qmul.bsky.social
Reposted by James Rudd
We're seeking a Clinical Lecturer in Cardiology to join us for high-quality research in the immune-inflammatory mechanisms of cardiovascular disease.
Find out the requirements + apply by 9 Feb: buff.ly/Fv2HheZ
@cam.ac.uk
@cuh.nhs.uk
Find out the requirements + apply by 9 Feb: buff.ly/Fv2HheZ
@cam.ac.uk
@cuh.nhs.uk
January 14, 2026 at 10:00 AM
We're seeking a Clinical Lecturer in Cardiology to join us for high-quality research in the immune-inflammatory mechanisms of cardiovascular disease.
Find out the requirements + apply by 9 Feb: buff.ly/Fv2HheZ
@cam.ac.uk
@cuh.nhs.uk
Find out the requirements + apply by 9 Feb: buff.ly/Fv2HheZ
@cam.ac.uk
@cuh.nhs.uk
Amazing to be part of this team - please read the paper and let us know what you think! @rouchelles.bsky.social
The IVORY trial was published in Nature Medicine last week. rdcu.be/eX8W3
This trial done in high-risk individuals who presented with heart attacks 🫀, showed low-dose interleukin-2 led to a
⬆️ Regulatory T cells
⬇️ Arterial inflammation 🔥
⬇️ trend in adverse cardiovascular outcomes ❤️🔥 at 2 years
This trial done in high-risk individuals who presented with heart attacks 🫀, showed low-dose interleukin-2 led to a
⬆️ Regulatory T cells
⬇️ Arterial inflammation 🔥
⬇️ trend in adverse cardiovascular outcomes ❤️🔥 at 2 years
January 15, 2026 at 10:18 AM
Amazing to be part of this team - please read the paper and let us know what you think! @rouchelles.bsky.social
Reposted by James Rudd
Great to see Professor James Rudd @18fdg.bsky.social awarded funding from @acceleratescience.bsky.social - @c2d3.cam.ac.uk for the ViTAL-CT, a new AI model to improve the speed and consistency of detecting high-risk coronary artery disease.🫀
Learn more👇
@cuh.nhs.uk
@vpd-hlri.bsky.social
Learn more👇
@cuh.nhs.uk
@vpd-hlri.bsky.social
We are delighted to announce the 2025 Accelerate – @c2d3.cam.ac.uk funded projects! 🎉
Projects will catalyse discoveries to accelerate scientific progress & create AI tools capable of delivering benefits for science & society.
Find out more: bit.ly/4rpvSiy
Projects will catalyse discoveries to accelerate scientific progress & create AI tools capable of delivering benefits for science & society.
Find out more: bit.ly/4rpvSiy
November 27, 2025 at 2:10 PM
Great to see Professor James Rudd @18fdg.bsky.social awarded funding from @acceleratescience.bsky.social - @c2d3.cam.ac.uk for the ViTAL-CT, a new AI model to improve the speed and consistency of detecting high-risk coronary artery disease.🫀
Learn more👇
@cuh.nhs.uk
@vpd-hlri.bsky.social
Learn more👇
@cuh.nhs.uk
@vpd-hlri.bsky.social